The activation of NLRP3 inflammasome and MyD88 myddosome increases the secretion of pro-inflammatory cytokines, such as IL-β, thereby contributing to chemotherapy-induced cardiac inflammation and fibrosis [33, 34]. The gene discussed is NLRP3; the disease is inflammation.